Farzaneh Modarresi

3.3k total citations · 2 hit papers
14 papers, 2.6k citations indexed

About

Farzaneh Modarresi is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Farzaneh Modarresi has authored 14 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Cancer Research. Recurrent topics in Farzaneh Modarresi's work include RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (4 papers) and Alzheimer's disease research and treatments (2 papers). Farzaneh Modarresi is often cited by papers focused on RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (4 papers) and Alzheimer's disease research and treatments (2 papers). Farzaneh Modarresi collaborates with scholars based in United States, Iran and Colombia. Farzaneh Modarresi's co-authors include Mohammad Ali Faghihi, Claes Wahlestedt, Ahmad M. Khalil, Barbara G. Sahagan, Georges St. Laurent, Douglas E. Wood, Caleb E. Finch, Todd E. Morgan, Paul J. Kenny and Marcel P. van der Brug and has published in prestigious journals such as Nature Medicine, Nature Biotechnology and PLoS ONE.

In The Last Decade

Farzaneh Modarresi

14 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase

2008 1.1k citations Mohammad Ali Faghihi, Farzaneh Modarresi et al. Nature Medicine profile →
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation

2012 528 citations Farzaneh Modarresi, Mohammad Ali Faghihi et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Farzaneh Modarresi

Since Specialization

Citations

This map shows the geographic impact of Farzaneh Modarresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzaneh Modarresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzaneh Modarresi more than expected).

Fields of papers citing papers by Farzaneh Modarresi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzaneh Modarresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzaneh Modarresi. The network helps show where Farzaneh Modarresi may publish in the future.

Co-authorship network of co-authors of Farzaneh Modarresi

This figure shows the co-authorship network connecting the top 25 collaborators of Farzaneh Modarresi. A scholar is included among the top collaborators of Farzaneh Modarresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzaneh Modarresi. Farzaneh Modarresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models 2023 ·Molecular Neurobiology ·Natalie Ricciardi, Farzaneh Modarresi, Ines Lohse, Nadja S. Andrade, (unknown), J. Mark Brown, (unknown), Brian Marples, Claes Wahlestedt, Claude‐Henry Volmar	4
2	JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1 2022 ·Journal of Alzheimer s Disease ·Jessica Dennison, Claude‐Henry Volmar, Farzaneh Modarresi, Danbing Ke, James Wang, (unknown), (unknown), Zuomei Li, James A. Timmons, Ines Lohse, Marshall A. Hayward, Shaun P. Brothers, Claes Wahlestedt	11
3	A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise 2021 ·Heliyon ·Farzaneh Modarresi, (unknown), (unknown), Natalie Ricciardi, Madina Makhmutova, Nathalie Khoury, Marco Magistri, Claude‐Henry Volmar, Claes Wahlestedt, Mohammad Ali Faghihi	6
4	Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes 2021 ·Scientific Reports ·(unknown), Runxia Tian, Chongxu Zhang, (unknown), (unknown), (unknown), (unknown), M. Sunil Mathew, (unknown), (unknown), (unknown), Sara Haddadi, Mukunthan Murthi, (unknown), (unknown), (unknown), Huda Asif, Farzaneh Modarresi, Mohammad Ali Faghihi, Mehdi Mirsaeidi	59
5	Splicing defect in FKBP10 gene causes autosomal recessive osteogenesis imperfecta disease: a case report 2018 ·BMC Medical Genetics ·(unknown), Kaoru Tabei, Hossein Moravej, Hassan Dastsooz, Farzaneh Modarresi, (unknown), Mohammad Ali Faghihi	4
6	Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene 2017 ·BMC Medical Genetics ·Parvaneh Karimzadeh, (unknown), Farzaneh Modarresi, Hassan Dastsooz, Hamid Nemati, (unknown), Bibi Shahin Shamsian, Soroor Inaloo, Mohammad Ali Faghihi	13
7	A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis 2017 ·BMC Medical Genetics ·Mohammadreza Bordbar, Farzaneh Modarresi, (unknown), Hassan Dastsooz, (unknown), Mohammad Ali Faghihi	3
8	Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen 2015 ·SLAS DISCOVERY ·(unknown), (unknown), Farzaneh Modarresi, Nathalie Khoury, Claes Wahlestedt, Mohammad Ali Faghihi	86
9	Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation breakdown → 2012 ·Nature Biotechnology ·Farzaneh Modarresi, Mohammad Ali Faghihi, Miguel A. López‐Toledano, (unknown), Marco Magistri, Shaun P. Brothers, Marcel P. van der Brug, Claes Wahlestedt	528
10	Knockdown of BACE1‐AS Nonprotein‐Coding Transcript Modulates Beta‐Amyloid‐Related Hippocampal Neurogenesis 2011 ·International Journal of Alzheimer s Disease ·Farzaneh Modarresi, Mohammad Ali Faghihi, Nikunj Patel, Barbara G. Sahagan, Claes Wahlestedt, Miguel A. López‐Toledano	134
11	RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts 2010 ·PLoS ONE ·Mohammad Ali Faghihi, Jannet Kocerha, Farzaneh Modarresi, Pär G. Engström, Alistair M. Chalk, Shaun P. Brothers, Eric Koesema, Georges St. Laurent, Claes Wahlestedt	38
12	Evidence for natural antisense transcript-mediated inhibition of microRNA function 2010 ·Genome biology ·Mohammad Ali Faghihi, Ming Zhang, Jia Huang, Farzaneh Modarresi, Marcel P. van der Brug, Michael A. Nalls, Mark Cookson, (unknown), Claes Wahlestedt	428
13	Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase breakdown → 2008 ·Nature Medicine ·Mohammad Ali Faghihi, Farzaneh Modarresi, Ahmad M. Khalil, Douglas E. Wood, Barbara G. Sahagan, Todd E. Morgan, Caleb E. Finch, Georges St. Laurent, Paul J. Kenny, Claes Wahlestedt	1147
14	A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome 2008 ·PLoS ONE ·Ahmad M. Khalil, Mohammad Ali Faghihi, Farzaneh Modarresi, Shaun P. Brothers, Claes Wahlestedt	143

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact